Pure Global
NCT06295289

Hybrid Closed-loop Insulin Delivery System in Perioperative Diabetic Patients: an Open-label, Randomized Controlled Trial

Huazhong University of Science and Technology·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetes Mellitus
Drug/Device/Intervention
Hybrid Closed-loop Insulin Delivery System
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Huazhong University of Science and Technology
Location
Wuhan, China
Timeline & enrollment
Phase
N/A
Start date
Oct 16, 2023
End date
Dec 04, 2024
Enrollment
54 participants
Primary outcome

TIR

Summary

Perioperative management of glucose levels remains challenging. The purpose of the study is
 to compare the hybrid closed-loop insulin delivery system with the standard insulin therapy (
 insulin pump with CGM, insulin dose controlled by physicians) in controlling glucose levels
 among patients in the perioperative period.

ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06295289
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06295289 through Pure Global AI's free database. This phase not specified trial is sponsored by Huazhong University of Science and Technology and is currently Recruiting. The study focuses on Diabetes Mellitus. Target enrollment is 54 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.